Search

everythinglearnresearchcommunity

for

Search:↓

Changing hair follicle identity could potentially reverse balding.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Higher DHEAS levels may cause hair loss in women by disrupting hair growth.

PGD2 stops hair growth and is higher in bald men with AGA.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Minoxidil can slow hair loss and promote regrowth but won't fully restore hair.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

Genetic factors influence hair traits like shape, color, and greying in Latin Americans.

Understanding hair follicle anatomy helps diagnose hair disorders.

Oxidative stress contributes to hair graying and loss as we age.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

FUE hair transplant is a promising method with benefits like less scarring, but requires a skilled surgeon and can damage hair follicles.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Impaired autophagy may cause hair loss by triggering early catagen.

Adiponectin reduces inflammation and bone loss in joint replacements.

Hair loss is caused by mechanical, thermal, and metabolic factors, not just hormones.

Hair loss is caused by mechanical, thermal, and metabolic stress, not just hormones.

Hair health is influenced by genetics, aging, and environmental factors, with proper care needed to maintain it.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Hair loss is mainly caused by a testosterone byproduct, and hair restoration surgery uses hair from the back and sides of the scalp.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

The book is a detailed guide on hair diseases and diagnosis, useful for skin disease experts.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

AGA is caused by genetics and androgens, treatable with finasteride and minoxidil.